NASDAQ:CGNX - Cognex Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $89.50
  • Forecasted Upside: -1.53 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 1 Strong Buy Ratings
$90.89
▲ +0.9 (1.00%)

This chart shows the closing price for CGNX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cognex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CGNX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CGNX

Analyst Price Target is $89.50
▼ -1.53% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Cognex in the last 3 months. The average price target is $89.50, with a high forecast of $120.00 and a low forecast of $63.00. The average price target represents a -1.53% upside from the last price of $90.89.

This chart shows the closing price for CGNX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 contributing investment analysts is to hold stock in Cognex. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 2 sell ratings
3/24/2020
  • 1 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 3 sell ratings
6/22/2020
  • 1 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 3 sell ratings
9/20/2020
  • 1 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
12/19/2020
  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 3 sell ratings
3/19/2021
  • 1 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 2 sell ratings
6/17/2021
  • 1 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 2 sell ratings
8/16/2021
  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/15/2021

Latest Recommendations

  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2021DA DavidsonReiterated RatingNeutralMedium
8/6/2021HSBCDowngradeBuy ➝ Hold$92.00Low
8/6/2021Needham & Company LLCReiterated RatingHoldHigh
5/19/2021Raymond JamesUpgradeOutperform ➝ Strong-Buy$100.00 ➝ $120.00Medium
5/7/2021Morgan StanleyBoost Price TargetUnderweight$68.00 ➝ $72.00Low
2/12/2021CowenBoost Price TargetOutperform$85.00 ➝ $105.00Low
2/12/2021Raymond JamesBoost Price TargetOutperform$75.00 ➝ $100.00Low
2/12/2021Morgan StanleyBoost Price TargetUnderweight$62.00 ➝ $68.00Low
1/20/2021Morgan StanleyBoost Price TargetUnderweight$57.00 ➝ $62.00Low
1/14/2021HSBCUpgradeHold ➝ BuyMedium
10/29/2020Morgan StanleyBoost Price TargetUnderweight$55.00 ➝ $57.00High
10/29/2020Robert W. BairdUpgradeUnderperform ➝ Neutral$63.00High
10/16/2020StephensInitiated CoverageOverweight$85.00Medium
9/4/2020Daiwa Capital MarketsDowngradeOutperform ➝ NeutralHigh
8/25/2020Wolfe ResearchInitiated CoverageUnderperform$47.00Medium
7/31/2020Morgan StanleyBoost Price TargetUnderweight$39.00 ➝ $55.00Medium
6/2/2020Robert W. BairdDowngradeNeutral ➝ Underperform$44.00 ➝ $45.00High
5/25/2020HSBCInitiated CoverageHold$55.00Medium
5/8/2020UBS GroupBoost Price TargetNeutral$43.00 ➝ $56.00Low
4/28/2020Robert W. BairdBoost Price TargetNeutral$39.00 ➝ $44.00Medium
4/28/2020Morgan StanleyBoost Price TargetUnderweight$36.00 ➝ $39.00Medium
4/28/2020Raymond JamesBoost Price TargetOutperform$48.00 ➝ $60.00High
4/17/2020JPMorgan Chase & Co.Boost Price TargetUnderweight$36.00 ➝ $40.00Low
3/23/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight$42.00 ➝ $36.00High
3/17/2020Morgan StanleyLower Price TargetEqual Weight$49.00 ➝ $42.00High
2/19/2020Morgan StanleyBoost Price TargetEqual Weight$47.00 ➝ $49.00Medium
12/12/2019UBS GroupInitiated CoverageNeutral$52.00High
11/1/2019Morgan StanleySet Price TargetHold$47.00Medium
10/29/2019Needham & Company LLCReiterated RatingHoldLow
9/24/2019Daiwa Capital MarketsSet Price TargetHold$53.00Low
9/23/2019DA DavidsonBoost Price TargetNeutral$40.00 ➝ $45.00Low
9/23/2019Robert W. BairdBoost Price TargetNeutral$42.00 ➝ $47.00Low
9/23/2019CowenReiterated RatingOutperform$50.00 ➝ $60.00Low
7/16/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell$45.00 ➝ $36.00High
7/10/2019Morgan StanleyLower Price TargetEqual Weight$47.00 ➝ $43.00Medium
5/3/2019Morgan StanleySet Price TargetHold$47.00Low
4/30/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
4/30/2019Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$46.00High
4/17/2019Gordon HaskettInitiated CoverageHold ➝ Hold$54.00Low
2/12/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$47.00 ➝ $50.00High
12/13/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$45.00 ➝ $47.00High
11/19/2018Berenberg BankInitiated CoverageBuy ➝ Buy$54.00High
11/1/2018Daiwa Capital MarketsSet Price TargetBuy$49.00Low
10/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$52.00 ➝ $40.00Medium
10/30/2018Needham & Company LLCLower Price TargetBuy ➝ Buy$52.00 ➝ $45.00High
10/16/2018Needham & Company LLCUpgradeHold ➝ Buy$52.00High
10/11/2018Morgan StanleySet Price TargetHold$57.00 ➝ $52.00High
10/2/2018DA DavidsonInitiated CoverageNeutral$57.00Low
8/24/2018Northcoast ResearchDowngradeBuy ➝ Neutral$54.00Medium
8/20/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$57.00Medium
8/1/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$40.10High
7/31/2018Northcoast ResearchSet Price TargetBuy$56.00High
7/31/2018Robert W. BairdReiterated RatingHold$48.00High
5/7/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$42.00Low
5/1/2018Raymond JamesUpgradeMarket Perform ➝ OutperformHigh
5/1/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$62.00 ➝ $40.00High
5/1/2018JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Hold$62.50 ➝ $42.00High
4/10/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$78.00 ➝ $55.00High
4/4/2018Northcoast ResearchUpgradeNeutral ➝ BuyHigh
4/3/2018JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$63.00Low
1/19/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy ➝ Buy$80.00Low
11/8/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$62.50N/A
10/31/2017Canaccord GenuityBoost Price TargetHold$47.50 ➝ $60.00N/A
10/31/2017Robert W. BairdBoost Price TargetNeutral$50.00 ➝ $62.00N/A
8/14/2017Wolfe ResearchUpgradeMarket Perform ➝ OutperformLow
8/8/2017CowenReiterated RatingOutperform$50.00 ➝ $67.50Low
8/2/2017CowenBoost Price TargetOutperform$50.00 ➝ $67.50Low
7/11/2017Wolfe ResearchInitiated CoveragePeer PerformMedium
7/11/2017CowenReiterated RatingBuy$50.00Medium
5/3/2017Canaccord GenuityReiterated RatingHold$32.50 ➝ $40.00Low
5/2/2017CowenLower Price TargetOutperform$50.00 ➝ $45.00Low
4/3/2017The Goldman Sachs GroupInitiated CoverageBuy ➝ BuyMedium
3/30/2017Summit RedstoneReiterated RatingBuyMedium
3/21/2017Needham & Company LLCReiterated RatingHoldHigh
3/15/2017Needham & Company LLCDowngradeBuy ➝ HoldLow
2/17/2017Needham & Company LLCReiterated RatingBuy$30.50 ➝ $40.00N/A
1/26/2017JPMorgan Chase & Co.Initiated CoverageNeutral$33.00N/A
12/8/2016Deutsche Bank AktiengesellschaftInitiated CoverageBuy$37.00N/A
12/2/2016Northcoast ResearchDowngradeBuy ➝ Neutral$29.50N/A
11/2/2016Canaccord GenuityReiterated RatingHoldN/A
11/1/2016Needham & Company LLCBoost Price TargetBuy$27.50 ➝ $30.50N/A
10/25/2016StephensInitiated CoverageEqual Weight$25.00N/A
9/20/2016Canaccord GenuitySet Price TargetHold$24.50N/A
(Data available from 9/16/2016 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/18/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/20/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/19/2021
  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/19/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/18/2021
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/18/2021
  • 4 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/17/2021
  • 6 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
9/16/2021

Current Sentiment

  • 6 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Cognex logo
Cognex Corp. engages in the provision of machine vision products that capture and analyze visual information in order to automate tasks in processes, where vision is required. The company was founded by Robert J. Shillman, William Silver and Marilyn Matz in 1981 and is headquartered in Natick, MA.
Read More

Today's Range

Now: $90.89
Low: $88.76
High: $90.94

50 Day Range

MA: $86.32
Low: $81.30
High: $91.19

52 Week Range

Now: $90.89
Low: $58.82
High: $101.82

Volume

17,182 shs

Average Volume

716,130 shs

Market Capitalization

$16.06 billion

P/E Ratio

53.46

Dividend Yield

0.27%

Beta

1.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Cognex?

The following Wall Street analysts have issued reports on Cognex in the last year: Cowen Inc, DA Davidson, HSBC Holdings plc, Morgan Stanley, Needham & Company LLC, Raymond James, Robert W. Baird, Stephens, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CGNX.

What is the current price target for Cognex?

6 Wall Street analysts have set twelve-month price targets for Cognex in the last year. Their average twelve-month price target is $89.50, suggesting a possible downside of 1.5%. Raymond James has the highest price target set, predicting CGNX will reach $120.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $63.00 for Cognex in the next year.
View the latest price targets for CGNX.

What is the current consensus analyst rating for Cognex?

Cognex currently has 1 sell rating, 4 hold ratings, 2 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CGNX, but not buy more shares or sell existing shares.
View the latest ratings for CGNX.

What other companies compete with Cognex?

How do I contact Cognex's investor relations team?

Cognex's physical mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company's listed phone number is (508) 650-3000 and its investor relations email address is [email protected] The official website for Cognex is www.cognex.com.